Nuvation Bio Inc. (NUVB)
NYSE: NUVB · Real-Time Price · USD
2.290
0.00 (0.00%)
Nov 5, 2024, 11:14 AM EST - Market open
Nuvation Bio Market Cap
Nuvation Bio has a market cap or net worth of $766.65 million as of November 5, 2024. Its market cap has increased by 189.41% in one year.
Market Cap
766.65M
Enterprise Value
479.10M
1-Year Change
189.41%
Ranking
Category
Stock Price
$2.29
Market Cap Chart
Since July 1, 2020, Nuvation Bio's market cap has increased from $181.60M to $766.65M, an increase of 322.16%. That is a compound annual growth rate of 39.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 1, 2024 | 573.30M | 73.41% |
| Dec 29, 2023 | 330.60M | -21.15% |
| Dec 30, 2022 | 419.30M | -77.35% |
| Dec 31, 2021 | 1.85B | 757.43% |
| Dec 31, 2020 | 215.90M | 18.89% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EyePoint Pharmaceuticals | 797.41M |
| LENZ Therapeutics | 781.73M |
| Standard BioTools | 779.42M |
| Adaptive Biotechnologies | 775.70M |
| Immunome | 774.74M |
| Pacira BioSciences | 758.79M |
| Annexon | 749.09M |
| Oculis Holding AG | 734.30M |